Generic Medicines Are Saving Your State Billions
Find out how much generic drugs save the U.S. in health care costs.
to download your state savings report.
Source: 2019 Generic Drug Access and Savings in the U.S. Report. Data compiled by IQVIA.
2019 Generic Drug Access and Savings in the U.S. Report
The 11th annual edition of AAM’s Savings and Access Report quantifies how much money American patients and our health care system are saving because of generic and biosimilar alternatives to brand-name prescription and biologic medications. In 2018, generic savings totaled $293 billion.
A Generic Summer Savings Tour: How Did Your State Do?
The 11th edition of the Association for Accessible Medicines’ annual Access and Savings Report reveals how much money American patients and taxpayers saved in 2018 through competition from generic drugs and biosimilar alternatives to brand-name biologic medicines.
Generic medicine prices have been falling for three years but some patients are experiencing higher out-of-pocket costs. When patients are burdened with higher Rx costs than ever, it makes no sense that there are forces keeping safe, effective and affordable generic and biosimilar medicines from getting approved, and being accessible to patients.